Author

Nigel R. Parker

University of Eastern Finland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Akshay SoodiD· 1 shared Alberto MartiniiD· 1 shared Colin P N Dinney· 1 shared Côme TholomieriD· 1 shared David J. McConkey· 1 shared Ganiraju C. ManyamiD· 1 shared I.-Ling Lee· 1 shared Jan Krzysztof Rudzinski· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akshay SoodORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer

Akshay Sood, Alberto Martini, Paulo Genitiano, Mikael Rauf, Ganiraju C. Manyam, Jan Krzysztof Rudzinski, Côme Tholomier, Roberto Contieri, I.-Ling Lee, Nigel R. Parker, Seppo Yla-Herttuala, David J. McConkey, Colin P N Dinney, Sharada Mokkapati

This paper shows that combining intravesical IFN gene therapy with oral Afatinib improves survival in mice with bladder cancer by targeting the ErbB resistance pathway.

Frontiers in Molecular Biosciences · Aug 10, 2026Peer-reviewedCancer Biology